FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Covid Antigen Home Test

[ Price : $8.95]

FDA clears an ACON Laboratories 510(k) for its Flowflex Covid-19 Antigen Home Test, which was originally authorized for emergency ...

Blood Storage Container is Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies the container system for the processing and storage of red blood cell components under red...

Takedas Adzynma Approved by FDA

[ Price : $8.95]

FDA approves Takedas Adzynma, a recombinant protein product designed for prophylactic or on‑demand enzyme replacement therap...

Cyltezo Exclusivity End Dates Recommended

[ Price : $8.95]

The CDER Office of Therapeutic Biologics and Biosimilars recommends expiration dates for first interchangeable exclusivity for Boe...

FDA Approves Recor Paradise System

[ Price : $8.95]

FDA approves a PMA for the Recor Medical Paradise renal denervation system to treat hypertension.

CareFusion Recalls Alaris Pump Module

[ Price : $8.95]

Becton Dickinsons CareFusion unit recalls its Alaris Patient Controlled Analgesia infusion pump module 8120 because the compatible...

Dont Approve Amryts Filsuvez NDA: Petition

[ Price : $8.95]

A Lassman Law petition filed for an unidentified client asks FDA not to approve an Amryt NDA for Filsuvez to treat cutaneous manif...

Compliance Delay on Cosmetic Registration

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Compliance Policy for Cosmetic Product Facility Registration and ...

Former Reviewer McGarry Joins Greenleaf Health

[ Price : $8.95]

Former FDA reviewer Sarah McGarry joins consulting firm Greenleaf Health as senior vice president of drug and biological products.

Rexulti Ads False and Misleading: OPDP

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion says two Otsuka Rexulti ads contain misleading presentations of the drugs efficacy....